Benzinga | May 6, 2021 07:05AM EDT

Madrigal Pharmaceuticals Q1 EPS $(3.32) Down From $(2.34) YoY

Madrigal Pharmaceuticals (NASDAQ:MDGL) reported quarterly losses of $(3.32) per share. This is a 41.88 percent decrease over losses of $(2.34) per share from the same period last year.